INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
EP

Enguent Jean-Pierre

Vice President, R&DSSCIK 0002114888

EDGAR filingsOpen in network
Disclosed transactions23
Buys / sells0 / 6
Max Insider Score32
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    SEALSQ CorpVice President, R&DSS · Apr 9, 2026
7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M
$200
20.0K sh
Nov 2, 2026
Nov 3, 2026
traded Nov 2, 2026
+1d
SEC FORM 4

Evidence

13
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$48K
35.0K sh
Nov 3, 2026Nov 3, 2026
traded Nov 3, 2026
+0dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
50.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
20.0K sh
Nov 2, 2026Nov 3, 2026
traded Nov 2, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$350
35.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
35.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

16
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$86K
35.0K sh
Oct 6, 2026Oct 7, 2026
traded Oct 6, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
50.0K sh
Oct 5, 2026Oct 7, 2026
traded Oct 5, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Sep 1, 2026Sep 3, 2026
traded Sep 1, 2026
+2dSEC FORM 4

Evidence

13
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$36K
15.0K sh
Sep 3, 2026Sep 3, 2026
traded Sep 3, 2026
+0dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Grant or award · 10b5-1 plan
A—
60.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

26
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$53K
15.0K sh
Jun 3, 2026Jun 3, 2026
traded Jun 3, 2026
+0dSEC FORM 4

Evidence

7
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Jun 1, 2026Jun 3, 2026
traded Jun 1, 2026
+2dSEC FORM 4

Evidence

23
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$47K
15.0K sh
May 6, 2026May 7, 2026
traded May 6, 2026
+1dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
May 4, 2026May 4, 2026
traded May 4, 2026
+0dSEC FORM 4

Evidence

0
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
May 4, 2026May 4, 2026
traded May 4, 2026
+0dSEC FORM 4

Evidence

32
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Open-market sale · 10b5-1 plan
SELL$33K
15.0K sh
Apr 8, 2026Apr 9, 2026
traded Apr 8, 2026
+1dSEC FORM 4

Evidence

5
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M$150
15.0K sh
Apr 6, 2026Apr 9, 2026
traded Apr 6, 2026
+3dSEC FORM 4

Evidence

5
EP
Enguent Jean-PierreVice President, R&DSS
LAESSEALSQ Corp
Option exercise · 10b5-1 plan
M—
15.0K sh
Apr 6, 2026Apr 9, 2026
traded Apr 6, 2026
+3dSEC FORM 4

Evidence